Compare AU
Compare DRUG vs. GDX
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the BetaShares Global Healthcare ETF - Currency Hedged (DRUG) and the Global Gold Miners (GDX). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
DRUG | GDX | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 63 | 66 |
Median incremental investment | $967.00 | $1,111.87 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,905.75 | $2,565.81 |
Average age group | 26 - 35 | > 35 |
Key Summary
DRUG | GDX | |
|---|---|---|
Strategy | DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars. | GDX.AX was created on 2015-06-26 by VanEck. The fund's investment portfolio concentrates primarily on materials equity. To achieve this investment objective, GDX.AX employs a passive management strategy of investing in the NYSE-listed GDX.AX issued and operated by VanEck in the United States. |
Top 3 holdings | CHF - SWISS FRANC (0 %) AUD - AUSTRALIA DOLLAR (0 %) DKK - DANISH KRONE (0 %) | Newmont Corp (11.86 %) Agnico Eagle Mines Ltd (10.43 %) Barrick Gold Corp (7.42 %) |
Top 3 industries | Other (75.53 %) Communication Services (33.53 %) Health Care (24.47 %) | Materials (87.60 %) Other (12.40 %) |
Top 3 countries | United States (71.71 %) Switzerland (8.14 %) Denmark (6.30 %) | Canada (52.17 %) United States (17.26 %) Australia (11.76 %) |
Management fee | 0.57 % | 0.53 % |
Key Summary
DRUG | GDX | |
|---|---|---|
Issuer | BetaShares | VanEck |
Tracking index | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD | NYSE Arca Gold Miners Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.57 % | 0.53 % |
Price | $8.15 | $60.45 |
Size | $182.401 million | $573.211 million |
10Y return | N/A | N/A |
Annual distribution yield (5Y) | 1.90 % | 1.26 % |
Market | ASX | ASX |
First listed date | 08/08/2016 | 26/06/2015 |
Purchase fee | $6.50 | $6.50 |
Community Stats
DRUG | GDX | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 63 | 66 |
Median incremental investment | $967.00 | $1,111.87 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,905.75 | $2,565.81 |
Average age group | 26 - 35 | > 35 |
Pros and Cons
DRUG | GDX | |
|---|---|---|
Pros |
|
|
Cons |
|
|
DRUG | GDX |
|---|---|
Lower exposure to AU market | Higher exposure to AU market |
Higher exposure to US market | Lower exposure to US market |
Higher management fee | Lower management fee |
Lower price growth | Higher price growth |
Higher distribution yield | Lower distribution yield |